The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

The pharmaceutical industry has experienced a substantial revolution with the introduction of novel technologies as well as ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...